Medical Thromboelastography Machine Market to Hit $1020.68 Mn by 2034
The medical thromboelastography machine market is rapidly growing due to TEG’s role in major surgeries and emergency bleeding control. Recent FDA approvals of Haemonetics' TEG 6s and Werfen’s ROTEM sigma have advanced this technology for use in cardiovascular, liver, and trauma care, improving patient outcomes.
Last Updated : 21 April 2026
Category: Therapeutic Area
Insight Code: 5312
Format: PDF / PPT / Excel